PIROLA, ALESSANDRA
 Distribuzione geografica
Continente #
NA - Nord America 6.030
EU - Europa 2.988
AS - Asia 2.500
SA - Sud America 377
AF - Africa 46
Continente sconosciuto - Info sul continente non disponibili 7
OC - Oceania 5
Totale 11.953
Nazione #
US - Stati Uniti d'America 5.877
SG - Singapore 1.039
CN - Cina 671
DE - Germania 640
IT - Italia 498
RU - Federazione Russa 407
SE - Svezia 399
IE - Irlanda 322
BR - Brasile 312
HK - Hong Kong 301
UA - Ucraina 194
GB - Regno Unito 188
VN - Vietnam 176
CA - Canada 115
FR - Francia 92
IN - India 70
FI - Finlandia 69
TR - Turchia 50
DK - Danimarca 34
ID - Indonesia 32
BE - Belgio 31
AR - Argentina 28
JP - Giappone 28
PL - Polonia 28
BD - Bangladesh 27
MX - Messico 25
ZA - Sudafrica 25
ES - Italia 19
IQ - Iraq 19
NL - Olanda 19
KR - Corea 15
AT - Austria 14
CO - Colombia 10
LT - Lituania 10
PK - Pakistan 10
IR - Iran 9
EC - Ecuador 7
EU - Europa 7
KE - Kenya 7
SA - Arabia Saudita 7
CH - Svizzera 6
JO - Giordania 6
PY - Paraguay 6
AE - Emirati Arabi Uniti 5
AZ - Azerbaigian 5
CZ - Repubblica Ceca 5
PE - Perù 5
UZ - Uzbekistan 5
IL - Israele 4
NP - Nepal 4
VE - Venezuela 4
AU - Australia 3
DO - Repubblica Dominicana 3
MA - Marocco 3
MY - Malesia 3
RO - Romania 3
AM - Armenia 2
BG - Bulgaria 2
CL - Cile 2
ET - Etiopia 2
GR - Grecia 2
GT - Guatemala 2
HN - Honduras 2
JM - Giamaica 2
LV - Lettonia 2
MU - Mauritius 2
PS - Palestinian Territory 2
SC - Seychelles 2
TH - Thailandia 2
TN - Tunisia 2
TT - Trinidad e Tobago 2
UY - Uruguay 2
BM - Bermuda 1
BO - Bolivia 1
BW - Botswana 1
CY - Cipro 1
DZ - Algeria 1
EG - Egitto 1
GE - Georgia 1
KG - Kirghizistan 1
LB - Libano 1
LK - Sri Lanka 1
NO - Norvegia 1
NZ - Nuova Zelanda 1
OM - Oman 1
PH - Filippine 1
PR - Porto Rico 1
PT - Portogallo 1
RS - Serbia 1
SK - Slovacchia (Repubblica Slovacca) 1
TO - Tonga 1
TW - Taiwan 1
Totale 11.953
Città #
Ann Arbor 1.069
Singapore 618
Ashburn 574
Woodbridge 418
Fairfield 378
Houston 353
Chandler 347
Frankfurt am Main 335
Dublin 312
Hong Kong 301
Wilmington 250
Milan 239
Dearborn 225
Jacksonville 177
Seattle 170
New York 155
Beijing 134
Cambridge 123
Los Angeles 116
Santa Clara 98
Princeton 86
Dallas 73
Nanjing 65
Göttingen 61
Shanghai 57
Munich 46
Ho Chi Minh City 40
Buffalo 38
Altamura 37
The Dalles 37
Hanoi 36
Lawrence 36
São Paulo 36
Moscow 35
Hefei 32
Brussels 31
Jakarta 29
Lachine 29
Boardman 28
Ottawa 28
Chicago 26
Nanchang 26
Shenyang 25
Dong Ket 23
Guangzhou 22
San Diego 22
Fürstenwalde 21
Helsinki 21
Andover 19
Fremont 19
Kocaeli 19
Warsaw 19
London 18
Montreal 18
Council Bluffs 17
Falls Church 17
Johannesburg 17
Orem 17
Toronto 17
Hebei 16
Tokyo 16
San Jose 15
Stockholm 15
Tianjin 15
Chennai 14
Nuremberg 14
Boston 13
Brooklyn 13
Changsha 13
Denver 13
Lissone 13
Manchester 13
Jiaxing 12
Jinan 12
Kunming 12
Phoenix 12
Ankara 11
Edmonton 11
Norwalk 11
Pune 11
Seoul 11
Atlanta 10
Lauterbourg 10
Mexico City 10
Mumbai 10
Pavia 10
Salt Lake City 10
Brasília 9
Charlotte 9
Chengdu 9
Düsseldorf 9
Poplar 9
Romola 9
Turku 9
Kent 8
Kiev 8
Nürnberg 8
Rio de Janeiro 8
Da Nang 7
Porto Alegre 7
Totale 8.090
Nome #
De novo UBE2A mutations are recurrently acquired during chronic myeloid leukemia progression and interfere with myeloid differentiation pathways 514
A bioinformatics procedure to identify and annotate somatic mutations in whole-exome sequencing data 452
Age and dPCR can predict relapse in CML patients who discontinued imatinib: The ISAV study 404
RNA-seq is a valuable complement of conventional diagnostic tools in newly diagnosed AML patients 395
OncoScore: A novel, Internet-based tool to assess the oncogenic potential of genes 383
The Risk of Relapse in CML Patients Who Discontinued imatinib Can Be Predicted Based on Patients Age and the Results of dPCR Analysis 364
SETBP1 induces transcription of a network of development genes by acting as an epigenetic hub 359
WHOLE-EXOME SEQUENCING OF A PHILADELPHIA NEGATIVE CHRONIC MYELOID LEUKEMIA PATIENT THROUGH THE EXON-CAPTURE TECHNIQUE 356
Recurrent SETBP1 mutations in atypical chronic myeloid leukemia 355
Erratum: OncoScore: a novel, Internet-based tool to assess the oncogenic potential of genes 353
A computational procedure to identify and annotate somatic mutations in next-generation sequencing data 349
Synergistic activity of ALK and mTOR inhibitors for the treatment of NPM-ALK positive lymphoma 319
Integrated Genomic, Functional, and Prognostic Characterization of Atypical Chronic Myeloid Leukemia 319
Recurrent ETNK1 mutations in atypical chronic myeloid leukemia 310
Evidence of ETNK1 Somatic Variants in Atypical Chronic Myeloid Leukemia 307
Concomitant BCORL1 and BRAF Mutations in Vemurafenib-Resistant Melanoma Cells 304
CEQer: A Graphical Tool for Copy Number and Allelic Imbalance Detection from Whole-Exome Sequencing Data 278
Identification of novel point mutations in splicing sites integrating whole-exome and RNA-seq data in myeloproliferative diseases 276
Whole-Exome Sequencing Data - Identifying Somatic Mutations 274
Integrated Analysis of Whole-Exome Sequencing and Micrornas Expression in Blast Crisis Transformation of Chronic Myeloid Leukemia 273
Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma 269
Gene expression signature of non-involved lung tissue associated with survival in lung adenocarcinoma patients 261
Read-through transcripts in normal human lung parenchyma are down-regulated in lung adenocarcinoma 259
Oncoscore, a Novel, Internet-Based Tool to Assess the Oncogenic Potential of Genes Can Differentiate Between CP-CML and BC-CML Associated Genes, and Between CP-CML Patients with Good and Bad Prognosis 257
Recurrent SETBP1 Mutations in Atypical Chronic Myeloid Leukemia 255
BCR and BCR-ABL regulation during myeloid differentiation in healthy donors and in chronic phase/blast crisis CML patients 249
FusionAnalyser: a new graphical, event-driven tool for fusion rearrangements discovery 249
Recurrent KIT D816V Mutation in Atypical Chronic Myeloid Leukemia 238
CML Patients Present Additional Mutations in Cancer Related Genes When Tested At Diagnosis 235
ETNK1 is an early event and SETBP1 a late event in atypical Chronic Myeloid Leukemia 234
Identification of a Novel Splicing Mutation in Blast Crisis Transformation of Chronic Myeloid Leukemia Integrating Whole-exome and RNA-Seq data 229
Synergistic activity of the Src/Abl inhibitor bosutinib in combination with imatinib 222
Whole-Exome Sequencing of 8 Atypical Chronic Myeloid Leukaemia Patients 222
Identification of Novel Point Mutations in Splicing Sites by the Integration of Exome and RNA Sequencing Data in Myeloproliferative Diseases 220
Whole-exome sequencing of matched chronic phase and blast crisis CML samples to reveal mechanisms of blast crisis transformation 219
Recurrent somatic mutations of FAT family cadherins induce an aggressive phenotype and poor prognosis in anaplastic large cell lymphoma 205
BCR AND BCR-ABL REGULATION DURING MYELOID DIFFERENTIATION IN HEALTHY DONORS AND CHRONIC PHASE-BLAST CRISIS CML PATIENTS 203
Abstract 3583: Drug-resistant NPM/ALK mutants show different sensitivity to second generation tyrosine kinase inhibitors 199
NPM/ALK mutants resistant to ASP3026 display variable sensitivity to alternative ALK inhibitors but succumb to the novel compound PF-06463922 198
Clonal evolution analysis identifies ETNK1 as an early event and SETBP1 as a late event in atypical Chronic Myeloid Leukemia 196
Synergistic Activity of ALK and mTOR Inhibitors for the Treatment of NPM-ALK Positive Lymphoma 182
Erratum: Treatment efficacy and resistance mechanisms using the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma (Molecular Cancer Research (2015) 13 (775-783)) 164
Identification of genetic polymorphisms modulating nausea and vomiting in two series of opioid-treated cancer patients 159
Gut virome-colonising Orthohepadnavirus genus is associated with ulcerative colitis pathogenesis and induces intestinal inflammation in vivo 159
Mechanisms of resistance to the second-generation ALK inhibitor AP26113 in human NPM-ALK-positive anaplastic large cell lymphoma cells 119
Totale 12.346
Categoria #
all - tutte 38.280
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 38.280


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/2021702 0 0 0 0 0 0 145 130 106 134 82 105
2021/2022637 47 70 75 52 32 61 36 33 33 64 51 83
2022/20231.330 143 400 129 128 104 196 12 76 79 17 28 18
2023/2024886 27 35 34 53 110 270 176 12 49 25 8 87
2024/20251.919 135 166 120 97 194 74 113 72 164 360 161 263
2025/20262.693 610 209 387 595 622 251 19 0 0 0 0 0
Totale 12.346